Here’s some stimulating news for people with HIV-related peripheral neuropathy (PN). An HIV-positive man received an experimental treatment in which a device was placed in his spine to disrupt the neural pathway responsible for causing PN—and two years later, he remains pain-free.   

Though still in early development, this new hope for people with HIV and PN couldn’t come at a better time. In February, an FDA advisory committee voted not to approve Qutenza, a skin patch based on the chemical capsaicin (derived from chili pepper), for PN.